Open access · CC-BY
via OpenAlex
Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A
Elisabetta Esposito, Valentyn Dzyhovskyi, Federico Santamaria, Lorenza Marvelli, Paola Boldrini, Paolo Mariani, Alessia Pepe, María Grazia Ortore, Mascia Benedusi, Giuseppe Valacchi, Luca Ferraro
Journal of Pharmacy & Pharmaceutical Sciences · 2025 · ▲ 1 citations
Abstract
Objective Despite the antioxidant, anti-inflammatory, and anti-cellular-aging activities of urolithin A (UroA), a naturally occurring postbiotic, its high lipophilicity hampers its pharmaceutical application. To overcome this limitation improving its stability and bioavailability, submicron emulsions (S-EMs) were designed. Methods Nineteen formulations (S-EM 1/S-EM 19) were prepared by two different methodologies. S-EMs were characterized evaluating macroscopical appearance and size distribution by photon correlation spectroscopy (PCS). One selected S-EM was loaded with UroA and characterized by PCS, transmission electron microscopy (TEM), small angle x-ray scattering (SAXS) and Fourier-transform infrared spectroscopy (FT-IR). Z potential, pH and syringeability were evaluated. UroA entrapment was studied efficiency by ultrafiltration and HPLC, while in vitro release by dialysis. Cytotoxicity was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) viability test on primary dermal human fibroblasts. The anti-inflammatory activity of S-EM-UroA was evaluated at 3, 6, and 24 h post-injection using the carrageenan-induced paw edema model in male C57BL/6 mice, and compared with UroA suspension and unloaded S-EM. Results The preformulative study enabled to select method and composition for S-EM preparation. S-EM 18 was selected for UroA loading (SEM-UroA), due to mean diameter, zeta potential, pH and syringeability suitable for intraperitoneal administration. The loading of UroA (0.2 mg/mL) did not influence S-EM physicochemical features, while maintaining technological properties for 3 months. In vitro drug release showed a biphasic profile, 2.35-fold faster in the case of SEM-UroA compared to the drug suspension. In vitro studies revealed absence of cytotoxicity at concentrations up to 5 µM. In vivo studies, conducted as a first step in assessing the potential of S-EM-UroA, demonstrated a dose-dependent anti-inflammatory effect. Specifically, S-EM-UroA at 2 mg/kg reduced paw edema at 24 h ( p < 00.5; One-Way ANOVA followed by Tukey’s test), and at 4 mg/kg significantly reduced edema at all time points ( p < 0.01), whereas the UroA suspension or S-EM had no effect on carrageenan-induced paw edema at any time point. Conclusion These findings underscore the potential of UroA loaded S-EM as an effective delivery system, demonstrating its superiority over simple UroA suspensions in enhancing the systemic anti-inflammatory effects of the postbiotic.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/jpps.2025.15553
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Esposito, E., Dzyhovskyi, V., Santamaria, F., Marvelli, L., Boldrini, P., Mariani, P., Pepe, A., Ortore, M.G., Benedusi, M., Valacchi, G., & Ferraro, L. (2025). Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A. <em>Journal of Pharmacy & Pharmaceutical Sciences</em>. https://doi.org/10.3389/jpps.2025.15553
Vancouver
Esposito E, Dzyhovskyi V, Santamaria F, Marvelli L, Boldrini P, Mariani P, et al. Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A. Journal of Pharmacy & Pharmaceutical Sciences. 2025. doi:10.3389/jpps.2025.15553.
BibTeX
@article{elisabetta2025Develo,
title = {Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A},
author = {Elisabetta Esposito and Valentyn Dzyhovskyi and Federico Santamaria and Lorenza Marvelli and Paola Boldrini and Paolo Mariani and Alessia Pepe and María Grazia Ortore and Mascia Benedusi and Giuseppe Valacchi and Luca Ferraro},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2025},
doi = {10.3389/jpps.2025.15553},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2022
Open access · CC-BY
Urolithin A Attenuates Hyperuricemic Nephropathy in Fructose-Fed Mice by Impairing STING-NLRP3 Axis-Mediated Inflammatory Response via Restoration of Parkin-Dependent Mitophagy
Nutrients 2024
Open access · CC-BY
Effect of Urolithin A on the Improvement of Circadian Rhythm Dysregulation in Intestinal Barrier Induced by Inflammation
GeroScience 2022
Open access · OA
Epigenetic clock and methylation studies in marsupials: opossums, Tasmanian devils, kangaroos, and wallabies
PLoS ONE 2011
Open access · CC-BY
Longevity in Mice Is Promoted by Probiotic-Induced Suppression of Colonic Senescence Dependent on Upregulation of Gut Bacterial Polyamine Production
Microorganisms 2020
Open access · CC-BY
Impact of Cyanidin-3-Glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-High Sucrose Diet-Induced Insulin Resistant Mice
Scientific Reports 2023
Open access · CC-BY